IV cannabidiol regulatory update

FDA granted Fast Track designation and EMA granted Orphan Drug designation to IV cannabidiol from GW to treat neonatal hypoxic-ischemic encephalopathy (NHIE). The phytocannabinoid found in Cannabis sa...